Navigation Links
AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results
Date:8/11/2009

other 2,952 2,207 4,092 4,013 ------------------------------------------------------------------------- 8,379 10,457 14,490 20,205 ------------------------------------------------------------------------- Operating expenses Cost of sales 4,545 4,758 8,239 9,362 Research and development costs, net of tax credits and grants 12,076 17,345 23,513 31,034 Selling, general and administrative 3,102 6,606 6,656 11,010 Depreciation and amortization Property, plant and equipment 331 397 642 766 Intangible assets 563 876 1,120 1,716 ------------------------------------------------------------------------- 20,617 29,982 40,170 53,888 ------------------------------------------------------------------------- Loss from operations (12,238) (19,525) (25,680) (33,683) ------------------------------------------------------------------------- Other income (expenses) Interest income 118 311 274 588 Interest expense - (53) (2) (68) Foreign exchange (loss) gain (960) (502) (60) 1,753 Loss on disposal of long-lived assets held for sale - (810) - (35) ------------------------------------------------------------------------- (842) (1,054) 212 2,238 ------------------------------------------------------------------------- Net loss for the period (13,080) (20,579) (25,468) (31,445) ---------
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... DUBLIN , July 28, 2014 ... the "Global Synthetic Biology Market 2014-2018" report ... The term synthetic biology covers the ... and organisms as well as the redesigning of natural ... is considered to be a form of extreme genetic ...
(Date:7/28/2014)... July 28, 2014 Immunomic Therapeutics, Inc. ... to further develop potential treatments for glioblastoma multiforme (GBM), ... combination with their patented vaccine platform, LAMP-vax. , ... are based on the work of John H. Sampson, ... The Preston Robert Tisch Brain Tumor Center at Duke ...
(Date:7/28/2014)... 28, 2014 The global market for ... 2020, according to a new study by Grand View ... demand for effective vaccines and drugs in an attempt ... needs is expected to drive market demand over the ... agricultural productivity via the use of genetically engineered seeds ...
(Date:7/28/2014)... Muncie, IN (PRWEB) July 28, 2014 ... Aeromodeling Center, in Muncie IN, is pleased to announce ... by the National Museum of the United States Air ... than a year-long process that concluded this spring with ... for the Dayton, OH museum. , The National ...
Breaking Biology Technology:Global Synthetic Biology Market 2014-2018 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4AMA’s National Model Aviation Museum Granted Full Civilian Museum Certification by the National Museum of the United States Air Force 2
... David Letterman, here are the top 10 reasons to be at ... can pick up some great toys for the kids. Attention-grabbing ... floor, where representatives of 61 nations and 48 states have set ... the giveaways. , , Crowd at BIO ...
... The state Assembly on Thursday passed AB 499, a proposed ... ,The bill would outlaw the cloning of embryos both for ... therapeutic cloning, the making of a cloned embryo for the ... if it were to become law would go up to ...
... - Educators and video-game developers gathered last week ... traditional classroom and textbook education models, which speakers agreed ... annual Games+Learning+Society conference was sponsored by ... of the Advanced Academic Distributed Learning (ADL) Co-Lab ...
Cached Biology Technology:From the BIO floor 2From the BIO floor 3Gaming technologies alter classroom, textbook models 2Gaming technologies alter classroom, textbook models 3Gaming technologies alter classroom, textbook models 4Gaming technologies alter classroom, textbook models 5
(Date:7/28/2014)... for Biologically Inspired Engineering at Harvard University today ... commercialized by a newly formed private company to ... medicine products. The announcement follows a ... Development (OTD) and the start-up Emulate Inc., relating ... Organs-on-Chips platform. , "This is a big ...
(Date:7/27/2014)... might have survived the asteroid strike that wiped them ... later in history, scientists say. , A fresh study ... helped palaeontologists to build a new narrative of the ... They found that in the few million years before ... was experiencing environmental upheaval. This included extensive volcanic activity, ...
(Date:7/27/2014)... potential for global climate change to cut food supplies. ... the interactions between increasing temperature and air pollution ... , A new study involving researchers at MIT shows ... policymakers need to take both warming and air pollution ... looked in detail at global production of four leading ...
Breaking Biology News(10 mins):Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Dinosaurs fell victim to perfect storm of events, study shows 2Study: Climate change and air pollution will combine to curb food supplies 2Study: Climate change and air pollution will combine to curb food supplies 3
... Calif. June 23, 2010. The city recreation programs of ... on natural resources themes such as wildlife, forestry, aquatics ... participants will explore their local environment, and learn about ... supported by a special program sponsored by the USDA ...
... A new animal model of atherosclerosis has allowed researchers to ... the initial stages of the process, before a plaque appears ... June 15 in Blood, the journal of the ... to definitively show that disturbances in the patterns of blood ...
... 2010) -- The p53 tumor suppressor gene, the "guardian ... mutated in many cancers. It encodes one of a family ... death. Mutations in p53 allow cells to escape normal growth ... book from Cold Spring Harbor Laboratory Press, The p53 ...
Cached Biology News:Summer day camps provide fun; environmental education activities for Humboldt County youth 2To predict atherosclerosis, follow the disturbed blood flow 2
MOUSE ANTI NEUROFILAMENTS 140+160 KD...
EGTA, 50 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
MOUSE ANTI HUMAN COMPLEMENT SC5B-9...
Human VEGF R Phycoerythrin Sampler (Cl 89106, 49560, 54733)...
Biology Products: